Polaryx Therapeutics, Inc. — Form C (Regulation Crowdfunding)
Polaryx Therapeutics, Inc. of Paramus, NJ filed a Form C (Regulation Crowdfunding) with the SEC on 2025-09-03. Target raise $15K, up to $5.0M. Offered through DEALMAKER SECURITIES LLC.
Offering
- Filed: 2025-09-03
- Form: C
- Accession: 0001213900-25-084152
- Target amount: $15K
- Maximum amount: $5.0M
- Security type: Common Stock
- Securities offered: 20,704
- Price: $0.7000
- Deadline: 2026-03-31
- Funding portal / intermediary: DEALMAKER SECURITIES LLC
- Intermediary file number: 008-70756
- Intermediary CRD: 000315324
Issuer
- CIK: 0002075320
- Website: www.polaryx.com
- Legal status: Corporation
- Organized in: WY
- Incorporated: 2014-08-22
- Address: South Tower, 140 E Ridgewood Avenue, Paramus, NJ, 07652
- Employees: 11
Financials (as filed)
- Total assets (most recent): $5.0M
- Cash (most recent): $4.6M
- Net income (most recent): $-30.4M
- Net income (prior): $-3.8M
People (1)
| Name | Role | Location |
|---|
| Alex Yang | Chief Executive Officer | Paramus, NJ |
Reg CF filing history (4)
More